To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subjects
Clinical trial NCT06022354 · COMPLETED
Trial details
- NCT number
- NCT06022354
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-23
- Primary completion
- 2025-03-18
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.